» Articles » PMID: 17885882

Diffusion Characteristics of Botulinum Neurotoxin Products and Their Clinical Significance in Cosmetic Applications

Overview
Publisher Informa Healthcare
Specialty Dermatology
Date 2007 Nov 21
PMID 17885882
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past decade, growth in the number and types of aesthetic procedures performed using botulinum neurotoxin has increased, along with the number of these products. As more options, along with emerging counterfeit agents, become available to clinicians, differences among preparations need to be considered in order to ensure optimal outcomes for patients. Once injected into the muscle, botulinum neurotoxin distributes within that tissue to produce the desired local effects. Diffusion, or the distribution of product beyond the target muscle, can be of concern because of the potential for local and systemic effects that result in muscle weakening away from the desired site. Several factors influence diffusion, including preparation characteristics (e.g. molecular size and structure), dosing and injection technique, and muscles injected. In this article, we discuss the accumulating preclinical and clinical data that differentiate botulinum neurotoxin agents with respect to their diffusion characteristics.

Citing Articles

Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System.

Nicoletti M, Anatriello A, Liguori V, Cantone A, Mauro G, Izzo I Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004476 PMC: 10675122. DOI: 10.3390/ph16111611.


Immunogenicity of botulinum toxin.

Wee S, Park E Arch Plast Surg. 2022; 49(1):12-18.

PMID: 35086302 PMC: 8795657. DOI: 10.5999/aps.2021.00766.


The effect of botulinum toxin injection dose on the appearance of surgical scar.

Chen Z, Chen Z, Pang R, Wei Z, Zhang H, Liu W Sci Rep. 2021; 11(1):13670.

PMID: 34211099 PMC: 8249595. DOI: 10.1038/s41598-021-93203-x.


Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.

de Sanctis Pecora C, Shitara D Toxins (Basel). 2021; 13(2).

PMID: 33670477 PMC: 7923088. DOI: 10.3390/toxins13020159.


Do complexing proteins provide mechanical protection for botulinum neurotoxins?.

Dressler D, Pan L, Adib Saberi F, Bigalke H J Neural Transm (Vienna). 2019; 126(8):1047-1050.

PMID: 31168666 DOI: 10.1007/s00702-019-02023-x.